Vieira, RaquelSouto, Selma B.Sánchez-López, E. (Elena)López-Machado, AnaSeverino, PatríciaJose, SajanSantini, AntonelloFortiuna, AnaGarcía López, María LuisaSilva, Amélia M.Souto, Eliana B.2020-06-192020-06-192019-10-101424-8247https://hdl.handle.net/2445/166338Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia together with disturbances in the metabolism of carbohydrates, proteins and fat, which in general results from an insulin availability and need imbalance. In a great number of patients, marketed anti-glycemic agents have shown poor effectiveness in maintaining a long-term glycemic control, thus being associated with severe adverse effects and leading to an emerging interest in natural compounds (e.g., essential oils and other secondary plant metabolites, namely, flavonoid-rich compounds) as a novel approach for prevention, management and/or treatment of either non-insulin-dependent diabetes mellitus (T2DM, type 2 DM) and/or Metabolic Syndrome (MS). In this review, some of these promising glucose-lowering agents will be comprehensively discussed31 p.application/pdfengcc-by (c) Vieira, Raquel et al., 2019http://creativecommons.org/licenses/by/3.0/esDiabetis no-insulinodependentSíndrome metabòlicaFitoteràpiaFarmacologiaGlucèmiaNon-insulin-dependent diabetesMetabolic syndromePhytotherapyPharmacologyBlood sugarSugar-lowering drugs for type 2 Diabetes Mellitus and Metabolic Syndrome Review of cassical and new compounds: Part-Iinfo:eu-repo/semantics/article7013022020-06-19info:eu-repo/semantics/openAccess31658729